Annual EBITDA:
-$351.67M+$75.76M(+17.72%)Summary
- As of today, IOVA annual EBITDA is -$351.67 million, with the most recent change of +$75.76 million (+17.72%) on December 31, 2024.
- During the last 3 years, IOVA annual EBITDA has fallen by -$22.95 million (-6.98%).
- IOVA annual EBITDA is now -2442066.67% below its all-time high of -$14.40 thousand, reached on December 31, 2009.
Performance
IOVA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$78.05M+$23.79M(+23.36%)Summary
- As of today, IOVA quarterly EBITDA is -$78.05 million, with the most recent change of +$23.79 million (+23.36%) on September 30, 2025.
- Over the past year, IOVA quarterly EBITDA has dropped by -$132.00 thousand (-0.17%).
- IOVA quarterly EBITDA is now -3902400.00% below its all-time high of -$2000.00, reached on December 31, 2009.
Performance
IOVA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$364.93M-$132.00K(-0.04%)Summary
- As of today, IOVA TTM EBITDA is -$364.93 million, with the most recent change of -$132.00 thousand (-0.04%) on September 30, 2025.
- Over the past year, IOVA TTM EBITDA has increased by +$23.39 million (+6.02%).
- IOVA TTM EBITDA is now -2534143.06% below its all-time high of -$14.40 thousand, reached on December 31, 2009.
Performance
IOVA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
IOVA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +17.7% | -0.2% | +6.0% |
| 3Y3 Years | -7.0% | +18.0% | +1.7% |
| 5Y5 Years | -76.9% | -37.0% | -45.7% |
IOVA EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -7.0% | +17.7% | -4.2% | +30.0% | -3.8% | +15.2% |
| 5Y | 5-Year | -76.9% | +17.7% | -37.0% | +30.0% | -45.7% | +15.2% |
| All-Time | All-Time | >-9999.0% | +17.7% | >-9999.0% | +30.0% | >-9999.0% | +15.2% |
IOVA EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$78.05M(+23.4%) | -$364.93M(-0.0%) |
| Jun 2025 | - | -$101.84M(+7.6%) | -$364.80M(-3.0%) |
| Mar 2025 | - | -$110.16M(-47.1%) | -$354.01M(-0.7%) |
| Dec 2024 | -$351.67M(+17.7%) | -$74.89M(+3.9%) | -$351.67M(+9.4%) |
| Sep 2024 | - | -$77.92M(+14.4%) | -$388.32M(+7.3%) |
| Jun 2024 | - | -$91.05M(+15.5%) | -$418.89M(+2.6%) |
| Mar 2024 | - | -$107.81M(+3.3%) | -$430.09M(-0.6%) |
| Dec 2023 | -$427.43M(-13.2%) | -$111.54M(-2.8%) | -$427.43M(-2.4%) |
| Sep 2023 | - | -$108.49M(-6.1%) | -$417.22M(-3.3%) |
| Jun 2023 | - | -$102.25M(+2.8%) | -$403.93M(-1.9%) |
| Mar 2023 | - | -$105.16M(-3.8%) | -$396.21M(-4.9%) |
| Dec 2022 | -$377.74M(-14.9%) | -$101.33M(-6.4%) | -$377.79M(-1.7%) |
| Sep 2022 | - | -$95.19M(-0.7%) | -$371.34M(-4.3%) |
| Jun 2022 | - | -$94.53M(-9.0%) | -$356.14M(-4.0%) |
| Mar 2022 | - | -$86.73M(+8.6%) | -$342.55M(-4.2%) |
| Dec 2021 | -$328.72M(-29.8%) | -$94.88M(-18.6%) | -$328.72M(-9.8%) |
| Sep 2021 | - | -$79.99M(+1.2%) | -$299.48M(-8.3%) |
| Jun 2021 | - | -$80.94M(-11.0%) | -$276.48M(-7.4%) |
| Mar 2021 | - | -$72.91M(-11.1%) | -$257.45M(-1.7%) |
| Dec 2020 | -$253.22M(-27.4%) | -$65.64M(-15.2%) | -$253.22M(-1.1%) |
| Sep 2020 | - | -$56.99M(+7.9%) | -$250.41M(-3.1%) |
| Jun 2020 | - | -$61.91M(+9.9%) | -$242.79M(-6.0%) |
| Mar 2020 | - | -$68.69M(-9.3%) | -$229.15M(-15.3%) |
| Dec 2019 | -$198.75M(-56.1%) | -$62.83M(-27.3%) | -$198.75M(-16.5%) |
| Sep 2019 | - | -$49.36M(-2.3%) | -$170.61M(-9.3%) |
| Jun 2019 | - | -$48.27M(-26.1%) | -$156.06M(-12.3%) |
| Mar 2019 | - | -$38.29M(-10.4%) | -$138.94M(-9.1%) |
| Dec 2018 | -$127.30M(-38.5%) | -$34.69M(+0.3%) | -$127.30M(-7.5%) |
| Sep 2018 | - | -$34.81M(-11.7%) | -$118.44M(-12.0%) |
| Jun 2018 | - | -$31.15M(-16.9%) | -$105.73M(-8.0%) |
| Mar 2018 | - | -$26.65M(-3.2%) | -$97.91M(-6.5%) |
| Dec 2017 | -$91.92M(-74.6%) | -$25.83M(-16.9%) | -$91.92M(-12.5%) |
| Sep 2017 | - | -$22.10M(+5.3%) | -$81.73M(-4.2%) |
| Jun 2017 | - | -$23.34M(-13.0%) | -$78.46M(-17.8%) |
| Mar 2017 | - | -$20.66M(-32.2%) | -$66.58M(-26.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | -$52.66M(-96.1%) | -$15.63M(+17.0%) | -$52.66M(-15.1%) |
| Sep 2016 | - | -$18.83M(-64.4%) | -$45.75M(-33.4%) |
| Jun 2016 | - | -$11.46M(-69.9%) | -$34.30M(-18.1%) |
| Mar 2016 | - | -$6.74M(+22.7%) | -$29.04M(-5.9%) |
| Dec 2015 | -$26.86M(-124.7%) | -$8.73M(-18.3%) | -$27.42M(-16.7%) |
| Sep 2015 | - | -$7.38M(-19.0%) | -$23.49M(-24.2%) |
| Jun 2015 | - | -$6.20M(-21.3%) | -$18.91M(-27.6%) |
| Mar 2015 | - | -$5.11M(-6.5%) | -$14.82M(-24.0%) |
| Dec 2014 | -$11.95M(+47.2%) | -$4.80M(-71.7%) | -$11.95M(-37.6%) |
| Sep 2014 | - | -$2.80M(-32.6%) | -$8.69M(+43.2%) |
| Jun 2014 | - | -$2.11M(+6.0%) | -$15.30M(-7.6%) |
| Mar 2014 | - | -$2.24M(-45.7%) | -$14.22M(-12.1%) |
| Dec 2013 | -$22.63M(-2467.7%) | -$1.54M(+83.6%) | -$12.68M(+1.4%) |
| Sep 2013 | - | -$9.41M(-815.0%) | -$12.86M(-153.2%) |
| Jun 2013 | - | -$1.03M(-46.2%) | -$5.08M(+10.8%) |
| Mar 2013 | - | -$703.00K(+59.2%) | -$5.70M(+29.9%) |
| Dec 2012 | -$881.50K(+95.7%) | -$1.72M(-5.8%) | -$8.13M(+22.5%) |
| Sep 2012 | - | -$1.63M(+1.1%) | -$10.48M(+28.4%) |
| Jun 2012 | - | -$1.64M(+47.5%) | -$14.65M(+37.8%) |
| Mar 2012 | - | -$3.13M(+23.1%) | -$23.55M(-11.8%) |
| Dec 2011 | -$20.54M(-2614.0%) | -$4.08M(+29.6%) | -$21.05M(-20.9%) |
| Sep 2011 | - | -$5.79M(+45.0%) | -$17.41M(-47.7%) |
| Jun 2011 | - | -$10.54M(-1547.0%) | -$11.79M(-786.7%) |
| Mar 2011 | - | -$640.10K(-46.2%) | -$1.33M(-75.6%) |
| Dec 2010 | -$756.80K(-5155.6%) | -$437.80K(-162.5%) | -$756.90K(-135.7%) |
| Sep 2010 | - | -$166.80K(-97.2%) | -$321.10K(-104.0%) |
| Jun 2010 | - | -$84.60K(-25.0%) | -$157.40K(-107.7%) |
| Mar 2010 | - | -$67.70K(-3285.0%) | -$75.80K(-426.4%) |
| Dec 2009 | -$14.40K(+74.2%) | -$2000.00(+35.5%) | -$14.40K(+45.5%) |
| Sep 2009 | - | -$3100.00(-3.3%) | -$26.40K(-3.9%) |
| Jun 2009 | - | -$3000.00(+52.4%) | -$25.40K(+31.5%) |
| Mar 2009 | - | -$6300.00(+55.0%) | -$37.10K(+33.5%) |
| Dec 2008 | -$55.80K | -$14.00K(-566.7%) | -$55.80K(-33.5%) |
| Sep 2008 | - | -$2100.00(+85.7%) | -$41.80K(-5.3%) |
| Jun 2008 | - | -$14.70K(+41.2%) | -$39.70K(-58.8%) |
| Mar 2008 | - | -$25.00K | -$25.00K |
FAQ
- What is Iovance Biotherapeutics, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Iovance Biotherapeutics, Inc.?
- What is Iovance Biotherapeutics, Inc. annual EBITDA year-on-year change?
- What is Iovance Biotherapeutics, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Iovance Biotherapeutics, Inc.?
- What is Iovance Biotherapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Iovance Biotherapeutics, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Iovance Biotherapeutics, Inc.?
- What is Iovance Biotherapeutics, Inc. TTM EBITDA year-on-year change?
What is Iovance Biotherapeutics, Inc. annual EBITDA?
The current annual EBITDA of IOVA is -$351.67M
What is the all-time high annual EBITDA for Iovance Biotherapeutics, Inc.?
Iovance Biotherapeutics, Inc. all-time high annual EBITDA is -$14.40K
What is Iovance Biotherapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, IOVA annual EBITDA has changed by +$75.76M (+17.72%)
What is Iovance Biotherapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of IOVA is -$78.05M
What is the all-time high quarterly EBITDA for Iovance Biotherapeutics, Inc.?
Iovance Biotherapeutics, Inc. all-time high quarterly EBITDA is -$2000.00
What is Iovance Biotherapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, IOVA quarterly EBITDA has changed by -$132.00K (-0.17%)
What is Iovance Biotherapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of IOVA is -$364.93M
What is the all-time high TTM EBITDA for Iovance Biotherapeutics, Inc.?
Iovance Biotherapeutics, Inc. all-time high TTM EBITDA is -$14.40K
What is Iovance Biotherapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, IOVA TTM EBITDA has changed by +$23.39M (+6.02%)